Programmed Cell Death-Ligand 1 (PD-L1) in Mismatch Repair Protein Deficient Colon Cancer: An Immunohistochemical and Genomic Profiling Study

被引：0
|
作者：
Lee, Hwajeong
Geiersbach, Katherine
Ainechi, Sanaz
Sheehan, Christine E.
Jones, David M.
Affoltez, Kajsa
Bronnez, Mary P.
Ross, Jeffrey S.
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
716
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [31] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569
  • [32] Discovery of a macrocyclic peptide inhibitor of programmed death-ligand 1 (PD-L1)
    Scola, Paul
    Gillis, Eric
    Boy, Kenneth
    Langley, David
    Donnelly, David
    Miller, Michael
    Lombardo, Louis
    Poss, Michael
    Mapelli, Claudio
    Gillman, Kevin
    Yeung, Kap-Sun
    Sun, Li-Qiang
    Grant-Young, Katherine
    Allen, Martin
    Poirier, Maude
    Bowsher, Michael
    Zhu, Juliang
    Li, Ling
    Lafont, Virginie
    Sanghvi, Nashith
    Yan, Chunhong
    Easter, John
    Lee, Ving
    Zhang, Yunhui
    Goodrich, Jason
    Bonacorsi, Samuel
    Cole, Erin
    Mull, Eric
    Mathur, Arvind
    Kempson, James
    Wu, Dauh-Rurng
    Zhao, Qian
    Wichroski, Michael
    Campellone, Shalyn
    Loubeau, Martine
    Cockett, Mark
    Gao, Mian
    Korman, Alan
    Selby, Mark
    Wang, Ying-Kai
    Chauhan, Vibha
    Reid, Patrick
    Nishikawa, Junichi
    Goto, Hiroko
    Logan, Randall
    Cutrone, Jenny
    Denton, Rex
    Haskell, Roy
    Johnson, Kim
    Benitex, Yulia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [33] Multifactorial regulators of tumor programmed death-ligand 1 (PD-L1) response
    Dorand, R. Dixon
    Petrosiute, Agne
    Huang, Alex Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1451 - S1454
  • [34] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    LABORATORY INVESTIGATION, 2017, 97 : 344A - 344A
  • [35] Molecular Mutations and Clinical Features That Affect Programmed Death-Ligand 1 (PD-L1) Immunohistochemical Expression in Mesothelioma
    Kwon, Jung Woo
    Chen-Yost, Heather
    Tjota, Melissa
    Segal, Jeremy
    Mueller, Jeffrey
    Husain, Aliya
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1634 - S1636
  • [36] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    MODERN PATHOLOGY, 2017, 30 : 344A - 344A
  • [37] Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
    Guzik, Katarzyna
    Zak, Krzysztof M.
    Grudnik, Przemyslaw
    Magiera, Katarzyna
    Musielak, Bogdan
    Torner, Ricarda
    Skalniak, Lukasz
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5857 - 5867
  • [38] Programmed Death-Ligand 1 (PD-L1) Changes in Non-Small-Cell Lung Cancer (NSCLC): Clinical, Pathologic, and Genomic Correlates
    Alden, S.
    Ricciuti, B.
    Spurr, L.
    Gupta, H.
    Lamberti, G.
    Li, Y.
    Sholl, L.
    Cherniack, A.
    Awad, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S406 - S407
  • [39] The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer
    Hsu, Ping-Chih
    Yang, Cheng-Ta
    Jablons, David M.
    You, Liang
    BIOMEDICINES, 2018, 6 (04)
  • [40] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer (vol 2019, 2989048, 2019)
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
12345